[ad_1]
Blue Water Vaccines, a company based in Cincinnati, Ohio, which is developing a universal influenza vaccine based on the technology developed at Oxford University, has raised $ 7 million in fund-raising funds. start-up.
CincyTech led the cycle, which included private investors affiliated with CincyTech.
The funding follows a preclinical study that provided early validation of the company's new approach to vaccine design.
The capital will now fund an additional preclinical study, followed by a targeted Phase 1 trial for 2020.
Led by Joseph Hernandez, CEO, Blue Water Vaccines uses technology developed by scientists at the University of Oxford to develop a unique vaccine that protects against all strains of influenza.
The company has obtained exclusive rights to the vaccine from Oxford University Innovation, the research marketing company of Oxford University in the United Kingdom.
FinSMEs
09/07/2019
Source link
